These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19228795)

  • 1. Single-chain insulins as receptor agonists.
    Rajpal G; Liu M; Zhang Y; Arvan P
    Mol Endocrinol; 2009 May; 23(5):679-88. PubMed ID: 19228795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant canine single chain insulin analogues: insulin receptor binding capacity and ability to stimulate glucose uptake.
    Adams JP; Holder AL; Catchpole B
    Vet J; 2014 Dec; 202(3):436-42. PubMed ID: 25457265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the connecting peptide in insulin biosynthesis.
    Liu M; Ramos-Castañeda J; Arvan P
    J Biol Chem; 2003 Apr; 278(17):14798-805. PubMed ID: 12590147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor binding protein-3 leads to insulin resistance in adipocytes.
    Chan SS; Twigg SM; Firth SM; Baxter RC
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6588-95. PubMed ID: 16189260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonism and antagonism at the insulin receptor.
    Knudsen L; Hansen BF; Jensen P; Pedersen TÅ; Vestergaard K; Schäffer L; Blagoev B; Oleksiewicz MB; Kiselyov VV; De Meyts P
    PLoS One; 2012; 7(12):e51972. PubMed ID: 23300584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pI-shifted insulin analogs with extended in vivo time action and favorable receptor selectivity.
    Kohn WD; Micanovic R; Myers SL; Vick AM; Kahl SD; Zhang L; Strifler BA; Li S; Shang J; Beals JM; Mayer JP; DiMarchi RD
    Peptides; 2007 Apr; 28(4):935-48. PubMed ID: 17328992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shikonin stimulates glucose uptake in 3T3-L1 adipocytes via an insulin-independent tyrosine kinase pathway.
    Kamei R; Kitagawa Y; Kadokura M; Hattori F; Hazeki O; Ebina Y; Nishihara T; Oikawa S
    Biochem Biophys Res Commun; 2002 Apr; 292(3):642-51. PubMed ID: 11922615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin and insulin-like growth factor I signaling pathways in rainbow trout (Oncorhynchus mykiss) during adipogenesis and their implication in glucose uptake.
    Bouraoui L; Capilla E; Gutiérrez J; Navarro I
    Am J Physiol Regul Integr Comp Physiol; 2010 Jul; 299(1):R33-41. PubMed ID: 20237304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol depletion disrupts caveolae and insulin receptor signaling for metabolic control via insulin receptor substrate-1, but not for mitogen-activated protein kinase control.
    Parpal S; Karlsson M; Thorn H; Strålfors P
    J Biol Chem; 2001 Mar; 276(13):9670-8. PubMed ID: 11121405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3-L1 adipocytes.
    Yaworsky K; Somwar R; Ramlal T; Tritschler HJ; Klip A
    Diabetologia; 2000 Mar; 43(3):294-303. PubMed ID: 10768090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor binding and biologic activity of biosynthetic human insulin and mini-proinsulin produced by recombinant gene technology.
    Kobayashi M; Sasaoka T; Sugibayashi M; Iwanishi M; Shigeta Y
    Diabetes Res Clin Pract; 1989 Jun; 7(1):25-8. PubMed ID: 2666066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.
    Veilleux A; Houde VP; Bellmann K; Marette A
    Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically engineered proinsulin constitutively processed and secreted as mature, active insulin.
    Groskreutz DJ; Sliwkowski MX; Gorman CM
    J Biol Chem; 1994 Feb; 269(8):6241-5. PubMed ID: 8119968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of WNK1 as a substrate of Akt/protein kinase B and a negative regulator of insulin-stimulated mitogenesis in 3T3-L1 cells.
    Jiang ZY; Zhou QL; Holik J; Patel S; Leszyk J; Coleman K; Chouinard M; Czech MP
    J Biol Chem; 2005 Jun; 280(22):21622-8. PubMed ID: 15799971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDGF- and insulin/IGF-1-specific distinct modes of class IA PI 3-kinase activation in normal rat retinas and RGC-5 retinal ganglion cells.
    Biswas SK; Zhao Y; Nagalingam A; Gardner TW; Sandirasegarane L
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3687-98. PubMed ID: 18421086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenite stimulated glucose transport in 3T3-L1 adipocytes involves both Glut4 translocation and p38 MAPK activity.
    Bazuine M; Ouwens DM; Gomes de Mesquita DS; Maassen JA
    Eur J Biochem; 2003 Oct; 270(19):3891-903. PubMed ID: 14511371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manganese Acts upon Insulin/IGF Receptors to Phosphorylate AKT and Increase Glucose Uptake in Huntington's Disease Cells.
    Bryan MR; Nordham KD; Rose DIR; O'Brien MT; Joshi P; Foshage AM; Gonçalves FM; Nitin R; Uhouse MA; Aschner M; Bowman AB
    Mol Neurobiol; 2020 Mar; 57(3):1570-1593. PubMed ID: 31797328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical effect of mitochondrial respiratory chain impairment on insulin signaling and glucose transport in adipose cells.
    Shi X; Burkart A; Nicoloro SM; Czech MP; Straubhaar J; Corvera S
    J Biol Chem; 2008 Nov; 283(45):30658-67. PubMed ID: 18779333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A peptide derived from an extracellular domain selectively inhibits receptor internalization: target sequences on insulin and insulin-like growth factor 1 receptors.
    Naranda T; Goldstein A; Olsson L
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11692-7. PubMed ID: 9326672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin receptor (IR) pathway hyperactivity in IGF-IR null cells and suppression of downstream growth signaling using the dual IGF-IR/IR inhibitor, BMS-754807.
    Dinchuk JE; Cao C; Huang F; Reeves KA; Wang J; Myers F; Cantor GH; Zhou X; Attar RM; Gottardis M; Carboni JM
    Endocrinology; 2010 Sep; 151(9):4123-32. PubMed ID: 20610571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.